Related Experiment Video
Updated: Mar 22, 2026

09:16
Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
Published on: June 3, 2018
7.8K
miR-19b controls cardiac fibroblast proliferation and migration
Chongjun Zhong1, Kun Wang1, Ying Liu2
1Department of Thoracic and Cardiovascular Surgery, The Second Affiliated Hospital of NanTong University, Nantong, China.
Journal of Cellular and Molecular Medicine
|April 11, 2016
Summary
MicroRNA-19b (miR-19b) promotes cardiac fibroblast growth and migration but does not affect collagen levels. Its cell-specific role suggests caution for systemic targeting in cardiac remodeling.
Area of Science:
- Cardiovascular Biology
- Molecular Medicine
- Fibrosis Research
Background:
- Cardiac fibrosis contributes significantly to heart dysfunction and mortality.
- Current treatments for cardiac fibrosis are limited, necessitating novel therapeutic strategies.
- MicroRNAs (miRNAs) show potential therapeutic roles, but their functions can be cell-specific.
Purpose of the Study:
- To investigate the role of microRNA-19b (miR-19b) in cardiac fibroblasts.
- To determine if miR-19b influences collagen production in cardiac fibroblasts.
- To identify potential targets of miR-19b in cardiac fibroblasts.
Main Methods:
- Cardiac fibroblasts were treated with miR-19b mimics and inhibitors.
- Cell proliferation and migration assays were performed.
- Collagen I expression and PTEN (Phosphatase and tensin homolog) levels were analyzed.
Main Results:
- miR-19b significantly promoted cardiac fibroblast proliferation and migration.
- miR-19b did not alter the expression of collagen I.
- PTEN was identified as a direct target of miR-19b, mediating its effects on fibroblast behavior.
Conclusions:
- miR-19b plays a cell-specific role in cardiac fibroblasts, promoting proliferation and migration via PTEN.
- Systemic targeting of miR-19b for cardiac remodeling may be problematic due to its cell-specific functions.
- Further in vivo investigation of miR-19b in cardiac remodeling is urgently required.

